Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
MindMaze is a Swiss neurotechnology company founded in 2012 as a spin-off of EPFL. Its digital therapeutics combine virtual reality, motion capture and neuroscience to rehabilitate stroke and brain injury patients. The company became the first Swiss digital health unicorn.
News
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
MindMaze Therapeutics Holding SA / Key word(s): Half Year Results MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update 27-Aug-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsi
Read more
Report
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics Holding SA / Key word(s): Miscellaneous MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor 12.08.2026 / 07:00 CET/CEST MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor Geneva, Switzer
Read more
Report
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
MindMaze Therapeutics Holding SA / Key word(s): Miscellaneous MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing 10-Aug-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53
Read more
Report
Empowered Patient Podcast: Immersive Precision Neurotherapy for Stroke and Parkinson's Rehabilitation
Zach Henderson, CEO at MindMaze Therapeutics, has designed a precision neurotherapeutic solution designed to offer a scalable, engaging and immersive platform for patients recovering from strokes or managing Parkinson's disease. The solution is deployed a
Read more
Report
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Holding SA / Key word(s): Study MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy 09.07.2026 / 07:0
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.